Gerhard Zlabinger

Title: Gerhard Zlabinger: Innovator in Pharmaceutical Composition

Introduction

Gerhard Zlabinger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory conditions. With a total of 2 patents, his work has the potential to impact medical practices and improve patient outcomes.

Latest Patents

Zlabinger's latest patents focus on the complement split product C4d for the treatment of inflammatory conditions. The first patent describes a pharmaceutical composition that utilizes C4d to treat various inflammatory conditions, including graft rejection, graft versus host disease, autoimmune diseases, and atopy. The invention emphasizes the use of C4d multimers and their applications in medicine. Additionally, it introduces a protein complex comprising C4d interacting with its ILT4 receptor, which can be utilized in screening methods. The patent also covers antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.

Career Highlights

Gerhard Zlabinger is affiliated with the Medical University of Vienna, where he conducts his research and development. His work has garnered attention for its innovative approach to addressing complex medical issues through pharmaceutical advancements.

Collaborations

Zlabinger has collaborated with esteemed colleagues such as Johannes Hofer and Peter Steinberger. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.

Conclusion

Gerhard Zlabinger's contributions to the field of pharmaceuticals, particularly through his patents on C4d, showcase his commitment to advancing medical science. His work holds promise for improving treatments for inflammatory conditions, making him a significant figure in the realm of innovation.